Indole-2-carboxamides as factor Xa inhibitors

Details for Australian Patent Application No. 2002351918 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Will, David William; Ritter, Kurt; Essrich, Melanie; WEHNER, Wolkmar; Nazare, Marc; Mattter, Hans

Agent Watermark

Pub. Number AU-B-2002351918

PCT Number PCT/EP02/12500

PCT Pub. Number WO2003/044014

Priority 01127809.0 22.11.01 EP

Filing date 8 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 3 April 2008

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/404 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 209/22 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01127809.0 22.11.01 EP

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002351918

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

3 April 2008 Application Accepted

  Published as AU-B-2002351918

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351919-ANTISENSE OLIGONUCLEOTIDES MODULATING BCL-2 EXPRESSION

2002351917-METHODS OF CONTROLLING USER ACCESS TO DIGITAL MEDIA CONTENT